Solid Biosciences (SLDB) Current Leases (2018 - 2025)
Solid Biosciences (SLDB) reported Current Leases of $281,000 for Q3 2025, down 73.3% from $1.05 million a year earlier and down 70.5% from the prior quarter.
Powered by 
Analysis
Solid Biosciences (SLDB) Current Leases (2018 - 2025) Analysis & Trends
At the end of FY2024, Solid Biosciences posted Current Leases of $1.23 million, up 162.5% from FY2023.
- Current Leases has a five-year compound annual growth rate of 45.9% (FY2019 to FY2024).
- By year, Current Leases came in at $469,000 in FY2023 (-29.8%), $668,000 in FY2022 (+187.9%), $232,000 in FY2021 (+11.5%) and $208,000 in FY2020 (+11.8%).
- The Q3 2025 figure ranks as the lowest quarterly Current Leases since Q1 2022.
- Year over year, Current Leases gained in three of the last five quarters, with growth averaging 52.4%.
- The high point for year-over-year Current Leases in five years was Q4 2022 (growth of 187.9%); the low point was Q3 2025 (a decline of 73.3%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $953,000 (Q2 2025), $1.1 million (Q1 2025) and $1.23 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | - |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Solid Biosciences | 1.08 Bn | -216.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 281,000.00 |
| Jun 30, 2025 | 953,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 525,000.00 |
| Mar 31, 2024 | 496,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Dec 31, 2022 | 668,000.00 |
| Sep 30, 2022 | 353,000.00 |
| Jun 30, 2022 | 412,000.00 |
| Mar 31, 2022 | 239,000.00 |
| Dec 31, 2021 | 232,000.00 |
| Sep 30, 2021 | 226,000.00 |
| Jun 30, 2021 | 220,000.00 |
| Mar 31, 2021 | 214,000.00 |
| Dec 31, 2020 | 208,000.00 |
| Sep 30, 2020 | 202,000.00 |
| Jun 30, 2020 | 197,000.00 |
| Mar 31, 2020 | 191,000.00 |
API Access
Solid Biosciences Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();